0001209191-19-030644.txt : 20190516
0001209191-19-030644.hdr.sgml : 20190516
20190516195100
ACCESSION NUMBER: 0001209191-19-030644
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190514
FILED AS OF DATE: 20190516
DATE AS OF CHANGE: 20190516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHULER JACK W
CENTRAL INDEX KEY: 0001021412
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 19833902
MAIL ADDRESS:
STREET 1: 100 N. FIELD DRIVE
STREET 2: SUITE 360
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-14
0
0000353569
QUIDEL CORP /DE/
QDEL
0001021412
SCHULER JACK W
12544 HIGH BLUFF DRIVE, SUITE 200
SAN DIEGO
CA
92130
1
0
1
0
Common Stock
2019-05-15
4
M
0
1661
0.00
A
3101149
D
Restricted Stock Units (Converted)
2019-05-14
4
A
0
875
0.00
A
Common Stock
875
875
D
Restricted Stock Units (Premium)
2019-05-14
4
A
0
262
0.00
A
Common Stock
262
262
D
Restricted Stock Units (Equity Grant)
2019-05-14
4
A
0
2100
0.00
A
Common Stock
2100
2100
D
Reflects release of restricted stock units that were previously reported on Form 4.
In addition to the shares reported on this Form 4 as directly owned by the Reporting Person, 65,000 shares are held indirectly by the Reporting Person's spouse and 1,105,263 shares are held indirectly by the Schuler Family Foundation. The Reporting Person disclaims all beneficial ownership of the shares owned by his spouse and the Schuler Family Foundation, except to the extent of his pecuniary interest, if any.
Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock.
The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule.
The restricted stock units vest on the date of the grant, May 14, 2019.
The restricted stock units vest on May 14, 2020.
Robert J. Bujarski, attorney-in-fact for Jack W. Schuler
2019-05-16